Coronavirus booster shots can help most vulnerable: WHO

By
Reuters
|
Hans Kluge, World Health Organization regional director for Europe — Reuters
Hans Kluge, World Health Organization regional director for Europe — Reuters

  • The statement appears to be more positive than past WHO statements.
  • WHO director-general had called for halt on 3rd shots.
  • Czechs join growing list of states offering boosters. 


COPENHAGEN: A senior World Health Organisation official Monday said that a COVID-19 booster shot is a way to keep the most vulnerable safe and not a luxury robbing people who have yet to have even a single jab.

The comments from WHO Europe head Hans Kluge appeared to be more positive than the UN health body's past assessments of the third vaccination being administered by a growing number of countries.

Last week, WHO Director-General Tedros Ghebreyesus said data on the third shots was inconclusive. He had earlier said they should be halted and authorities should focus on getting the doses to poorer nations.

On Monday, Kluge told a press briefing that more studies were showing that third doses protect vulnerable people.

"A third dose of vaccine is not a luxury booster (that is) taken away from someone who is still waiting for a first jab. It's basically a way to keep the most vulnerable safe," he said.

Kluge said more evidence was still needed and urged European countries with excess vaccines to share them with other states, particularly in Eastern Europe and Africa.

An increase in COVID-19 transmission rates across Europe over the last two weeks, combined with low levels of vaccination in some countries, was "deeply worrying", he added.

The Czech Republic said on Monday it would offer booster shots to anyone vaccinated at least eight months earlier, joining a growing list of countries stepping up measures to curb the spread of the coronavirus Delta variant.

Israel began offering a COVID-19 booster to children as young as 12 on Sunday.

In response to the WHO director-general's comments last week, Pfizer and BioNTech said a third dose of its vaccine, the most widely used in the Western world, spurred more than three times as many antibodies against the coronavirus as the second shot.